Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- Human Papillomavirus Vaccines
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Single group exploratory studyMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 12 years and 18 years
- Gender
- Only males
Description
This is a one group exploratory study. The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.
This is a one group exploratory study. The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.
Tracking Information
- NCT #
- NCT03431246
- Collaborators
- Centers for Disease Control and Prevention
- Investigators
- Study Chair: Gaston DeSerres, MD, PhD Quebec Public Health Institute
Get Well Soon